mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
much-hyped research compound targeting prolactin receptor in scalp
a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor
highly targeted anti-androgen that might have minimal systemic effects